Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD(65)-induced immune response

AIMS/HYPOTHESIS: A European Phase III trial of GAD formulated with aluminium hydroxide (GAD-alum) failed to reach its primary endpoint (preservation of stimulated C-peptide secretion from baseline to 15 months in type 1 diabetes patients), but subgroup analysis showed a clinical effect when particip...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetologia
Asıl Yazarlar: Tavira, Beatriz, Cheramy, Mikael, Axelsson, Stina, Åkerman, Linda, Ludvigsson, Johnny, Casas, Rosaura
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487599/
https://ncbi.nlm.nih.gov/pubmed/28357504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-017-4263-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller